Seminars in Oncology
Volume 35, Issue 4 , Pages 388-400 , August 2008

Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia

  • Sylvie D. Freeman

      Affiliations

    • Departments of Immunology and Haematology, University of Birmingham, Birmingham, UK.
    • ,
  • Jelena V. Jovanovic

      Affiliations

    • Division of Genetics and Molecular Medicine, King's College, London, UK.
    • ,
  • David Grimwade

      Affiliations

    • Division of Genetics and Molecular Medicine, King's College, London, UK.
    • Corresponding Author InformationAddress correspondence to David Grimwade, PhD, Cancer Genetics Lab, Department of Medical and Molecular Genetics, 8th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(08)00119-X

doi: 10.1053/j.seminoncol.2008.04.009

Seminars in Oncology
Volume 35, Issue 4 , Pages 388-400 , August 2008

Article Tools

* Image Usage & Resolution